Qube Research & Technologies LTD Keros Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 27,941 shares of KROS stock, worth $330,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,941
Previous 31,235
10.55%
Holding current value
$330,821
Previous $1.43 Million
13.67%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KROS
# of Institutions
177Shares Held
30.1MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$29.8 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$22.5 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$22 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$18 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$17.9 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $305M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...